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A B S T R A C T  
Objective: To determine the immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in different 
histopathological grades of mucoepidermoid carcinoma (MEC) in salivary glands. 
Patients and Methods: This cross-sectional study was conducted from August 2015 to September 2016 at Armed 
Forces Institte of Patholgy Rawalpindi (AFIP), to determine the immunohistochemical expression of Epidermal Growth 
Factor Receptor (EGFR) in different histopathological grades of mucoepidermoid carcinoma (MEC) in salivary glands. 
Thirty cases of MEC were retrieved from record files along with their paraffin blocks at AFIP, Rawalpindi. New 
histological diagnosis was made on freshly prepared Hematoxylin and Eosins section followed by application and 
analysis by immunostaining. Chi-square test was used to find the effect of EGFR on different grades of MEC. 
Results: Out of 30 cases, 24 cases were positive for EGFR. In case of low-grade mucoepidermoid carcinoma, 8 cases 
were weak positive, whereas remaining six were negative. Out of eight cases of intermediate grade mucoepidermoid 
carcinoma, 3 were week positive, whereas remaining five are strong positive. In high grade mucoepidermoid out of eight 
cases seven were strong positive. P-value for EGFR was calculated as .036. EGFR expression increased with increase 
in grade of tumor. 
Conclusion: The expression of EGFR increased with increase in grade of tumor. 
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I n t r o d u c t i o n  
 
Tumors of salivary glands have an important place in oral 
and maxillofacial pathology, having incidence of 5% 
around world.1 Mucoepidermoid carcinoma (MEC) is the 
most common malignant tumor of salivary glands, 
accounting for 15.3% of all tumors and 56.9% of 
malignant tumors .2 This tumor is composed of three 
intermixed type of cells: mucin-producing cells, 
intermediate cells or clear cells, and squamoid cells.3 
Mucoepidermoid carcinoma shows a variety of biological 
behavior that is correlated with histopathological grades of 
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tumor.4 All treatment plans are based exclusively on 
histopathological grades. Number of microscopic grading 
systems based on specific microscopic parameters have 
been described to find the grades of mucoepidermoid 
carcinoma.5 EGFR is a “tyrosine kinase receptor” of ErbB 
family. EGFR is a membrane glycoprotein and has an 
extracellular ligand -binding domain, a transmembrane 
lipophilic part and an intracellular protein kinase domain. 
EGFR is present on chromosome 7p12 and in many types 
of cancers. It is involved in proliferation, angiogenesis and 
metastasis of cancer cells. EGFR encodes membrane 
glycoprotein that is activated by phosphorylation.6-8 
In many cases of MEC of salivary glands, EGFR protein is 
strongly expressed.9 In high grade of MEC, the oncogenic 
glycoprotein MUC1 is greatly expressed.10 MUC1 react 
with EGFR and cause activation of MAPK in mouse 
model. In MEC of salivary glands, ERK1/2 MAPKs 
expression is high in high grade MEC. 
P a t i e n t s  a n d  M e t h o d s  
This cross-sectional study was conducted from August 
2015 to September 2016 The study included thirty cases 
of mucoepidermoid carcinoma. The data was collected 
from clinical histories given with each case. Blocks were 
cut and stained with Hematoxylin and Eosin stains. 
Necrosed, scanty and autolysed tissue samples were 
excluded.  After diagnosing on microscopy, 
histopathological grading was done according to Auclair 
et al and Goode criteria.11,12 
Expression of EGFR on different grades of MEC was 
calculated by evaluating the percent of positive stained 
cells under the objective lens of power 40 with 
microscope.12 Positive staining appeared as a linear to 
finely granular pattern in cell membrane and adjacent 
cytoplasm. Chi-square test was used to find out the 
association of EGFR with different grades of tumor. P 
value >0.05 was taken as significant 
R e s u l t s  
Among 30 cases, 23 patients were males and remaining 7 
were females.  Anatomically, 22 patients had tumor in 
parotid glands, while 4 had in submandibular areas. Other 
tumors were in palate, retromolor area, and in posterior 
1/3 of tongue. Most of patients had age between 40 to 60 
years. 
Immunohistochemical labeling patter:EGFR was applied 
to all 30 cases of Mucoepidermoid carcinoma. Both 
membranous and cytoplasmic stainings were considered. 
Among thirty cases eight cases were negative (-), while 
24 were positive. Out of 24 positive 16 were weak positive 
(+), while 8 were strong positive (++). The low grade MEC 
was diagnosed in 14 cases, out of these 6 cases were 
negatively stained (-) and remaining 8 were weak positive 
(+). In intermediate grade 
MEC, 3 cases were weak positive (+) while 5 cases were 
strong positive (62.5%), where as in high grade MEC one 
case was weak positive (12.5%) while the rest 7 were 
strong positive (87.5%) Chi-square test was applied to 
evaluate the association of EGFR and grades of tumor. P 
value of .036 was calculated and was significant. (Table 
3). 
 
Table 1: Scoring System 
Intra cystic component <20% 2 Points 
Neural invasion present 2 Points 
Necrosis 2 Points 
Mitosis (4 or more per 10 HPF) 3 Points 
Anaplasia 4 Points 
The quantitative grading system by these scores is: 
Low grade 0-4points 
Intermediate grade 5-6points 
High   grade 7-14points 
 
Table 2:Score Assessment of Immunoreactions 
Score Assessment 
Negative  <5% of positive cells 
Week positive 5 -50%of positive cells 
Strong positive >50% of positive score 
 
Table 3: Expression of EGFR in different grades of 
tumors 
Grades 
>50% 
(++) 
5-50% 
(+) 
<5% 
(-) Total 
P-
value 
Low 0 8 6 14 
0.036 
Intermediate 5 3 0 8  
High 5 1 0 8  
Total 10 12 6 30  
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igure 1: Strong membranous positivity of EGFR in 
High grade Mucoepidermoid carcinoma (40x100) 
 
Figure: 2 High membranous positivity of EGFR in 
High grade MEC (10x10 Magnification) 
D i s c u s s i o n  
The EGFR/ErbB1 is a gene located on chromosome 
7p12. This gene encodes membrane glycoprotein that is 
activated by phosphorylation. This activation induces a 
downstream signalling transduction cascade.13 It is over 
expressed in many tumors like head and neck tumors, 
glioblastoma, lung, breast, ovaries and bladder. In the 
present study, we evaluated the expression of EGFR on 
different histopathological grades of MEC. 
There are few studies present in literature showing 
expression of EGFR on MEC. In study conducted by 
Khiavi et al in 2012, out of 40 patients 2 were negative 
(4.3%), 12 week positive (26.1%) and 32 were strong 
positive (69.6%). The EGFR expression was cytoplasmic 
that is contrary to present study, as it had both 
cytoplasmic and membranous expressions. In another 
study conducted by Al-Ani in 201214, out of seventeen 
patients all were EGFR immunopositive. No statistical 
significant correlation was seen among marker and 
grading systems. According to above mentioned study, 9 
cases were weak positive and remaining 8 cases were 
strong positive.  EGFR in this study showed membranous 
expression. 
In 2010, Lujan et al conducted a study to check relation of 
EGFR expression in salivary glands MEC of high grade.15 
Out of 42 cases, 34(79%) cases were positive for protein 
expression. Expression of EGFR was high in high grade 
MEC, so it was more positive in aggressive tumors. They 
considered only continuous membranous staining of 
EGFR as strong positive. In contrast, we considered both 
cytoplasmic and membranous staining.  
In a study conducted by Hoyek-Gebeily et al in 2007, in 
which they checked the prognostic significance of EGFR 
in MEC of the salivary gland, 75% of cases are positive 
for EGFR staining.16 They considered only membranous 
staining and found high expression of EGFR in high grade 
so have poor prognosis. 
C o n c l u s i o n  
Expression of EGFR is strongly positive in high grade 
MEC and in few cases of intermediate grade MEC. In low 
grade MEC, EGFR has both negative and week positive 
expression. EGFR showed both membranous and 
cytoplasmic expression. 
R e f e r e n c e s  
1. Neville BW, Damm DD, Allen CM, Bouquot JE. Oral 
and Maxillofacial Pathology.3rded. Elsevier Health 
Sciences; 2015 
2. Gill MS, Muzaffar S, Soomroi IN, Hussainy AS, 
Pervez S, Hasan SH. Morphological patterns of 
salivary glands tumors. J Pak Med Assos 2001; 
51(10):343-46. 
3. Bai S, Clubwala R, Alder E. Salivary mucoepidermoid 
carcinoma: A multi institutional review of 76 patients. 
Head and Neck Pathol  2001 ; 7(2): 105-112. 
4. Hoyek – Gebeily J, Nehme E,  Aftimos G, Sader-
Ghorra C, Sargi Z, Haddad A. Prognostic significance 
of EGFR, P53 and E-cadherin in mucoepidermoid 
cancer of salivary glands. J Med Liban 2007; 
55(2):83-8. 
5. Auclair PL, Goode RK, Ellis GL. Mucoepidermoid 
carcinoma of intraoral salivary glands evaluation and 
application of grading criteria in 143 cases. Cancer. 
1992;69(8):2021-30 
6. Seshacharyulu P, Ponnusamy MP, Haridas D. 
Targeting the EGFR signaling pathway in cancer 
                            234 JIMDC   2017  234 
therapy. Expert Opinion Ther Targets 2012; 16(1):15-
31. 
7. Han W, Wen H. Landscape of EGFR signaling 
network in human cancers: biology and therapeutic 
response in relation to receptor subcellular locations. 
Cancer Lett 2012; 318(2):124-134. 
8. Pai SI, Weftra WH. Landscape of EGFR signaling 
network in human cancers: Biology and therapeutic 
response in relation to receptor subcellular locations. 
Cancer Left 2009; 318(2):124-134. 
9. Shang J, Shui Y, Sheng L, Wang K, Hu Q, Wei Q. 
Epidermal growth factor receptor and human 
epidermal growth factor 2 expression in parotid 
mucoepidermoid carcinoma : possible implication for 
targeted therapy 2007; 19(2): 435-440. 
10. Alos L, Castillo M, Nadal A, Caballero, Mardesa A, 
Mallofre C, Palacin A, Cardesa A. Adenosquamous 
carcinoma of head and neck: criteria for diagnosis  in 
a study of 12 cases. Histopathology 2004; 44(6):570-
579. 
11. Handra - Luca A, Lamas G, Bertrand JC, Fouret P. 
MUC1, MUC2, MUC4, MUC5AC expression in 
salivary gland mucoepidermoid carcinoma: diagnostic 
and prognostic implications. Am J surg pathol 2005; 
29(7): 881-889. 
12. Khiavi MM, Vosouughhosseini S, Saravani S, Halimi 
M. Immunohistochemical correlation of epidermal 
growth factor receptor and c-erb with 
histopathological grading of mucoepidermoid 
carcinoma. J. Can. Res. Therp 2012; 8(4): 586-590. 
13. Klapper LN, Kirschbaum MH, Sela M, Yarden Y. 
Biochemical and clinical implications of ErbB/HER 
signaling network of growth factor receptors. Adv 
Cancer Res 1999; 77: 25-79. 
14. Al- Ani, S A, Abdullah BH. Evaluation of epidermoid 
growth factor receptor (EGFR), proliferation (Ki- 67) 
and apoptosis (P53) in salivary mucoepidermoid 
carcinoma in relation to tumor grade. J Bagh College 
Dentistry 2012; 24(2): 43-47. 
15. Lujan B, Hakim S, Moyano S, Nadal A, Caballero M, 
Diaz A, Valera A. Activation of the EGFR/ERK 
pathway in high-grade mucoepidermoid carcinoma of 
the salivary glands. British Journal of Cancer 2010; 
103(4) :510-516.
 
